E Fund Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.8M | Buy |
5,329
+417
| +8% | +$219K | 0.13% | 95 |
|
|
2025
Q1 | $3.12M | Buy |
4,912
+1,714
| +54% | +$1.09M | 0.15% | 96 |
|
|
2024
Q4 | $2.28M | Buy |
3,198
+929
| +41% | +$662K | 0.11% | 101 |
|
|
2024
Q3 | $2.39M | Sell |
2,269
-70
| -3% | -$73.6K | 0.12% | 84 |
|
|
2024
Q2 | $2.46M | Buy |
2,339
+646
| +38% | +$679K | 0.14% | 73 |
|
|
2024
Q1 | $1.63M | Sell |
1,693
-118
| -7% | -$114K | 0.1% | 85 |
|
|
2023
Q4 | $1.59M | Sell |
1,811
-22
| -1% | -$19.3K | 0.1% | 65 |
|
|
2023
Q3 | $1.51M | Buy |
1,833
+113
| +7% | +$93K | 0.11% | 67 |
|
|
2023
Q2 | $1.24M | Sell |
1,720
-85
| -5% | -$61.1K | 0.1% | 68 |
|
|
2023
Q1 | $1.48M | Sell |
1,805
-128
| -7% | -$105K | 0.11% | 68 |
|
|
2022
Q4 | $1.4M | Sell |
1,933
-201
| -9% | -$145K | 0.12% | 70 |
|
|
2022
Q3 | $1.47M | Sell |
2,134
-49
| -2% | -$33.8K | 0.14% | 70 |
|
|
2022
Q2 | $1.29M | Buy |
2,183
+375
| +21% | +$222K | 0.12% | 77 |
|
|
2022
Q1 | $1.26M | Buy |
1,808
+141
| +8% | +$98.5K | 0.04% | 72 |
|
|
2021
Q4 | $1.05M | Buy |
1,667
+5
| +0.3% | +$3.16K | 0.04% | 105 |
|
|
2021
Q3 | $1.01M | Buy |
+1,662
| New | +$1.01M | 0.04% | 91 |
|
|
2021
Q1 | $821K | Buy |
+1,736
| New | +$821K | 0.07% | 102 |
|